Vehicle, Cenegermin
NGF-TBI-201
Phase 2 small_molecule active
Quick answer
Vehicle, Cenegermin for Subacute Moderate to Severe Traumatic Brain Injury (TBI) is a Phase 2 program (small_molecule) at Dompe' Farmaceutici S.p.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dompe' Farmaceutici S.p.A.
- Indication
- Subacute Moderate to Severe Traumatic Brain Injury (TBI)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active